Giovanna Pitarresi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Giovanna Pitarresi has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Gaetano Giammona
Università degli Studi di Palermo
8 shared publicationsG. Giammona
Dipartimento di Chimica e Tecnologie Farmaceutiche, Università di Palermo, via Archirafi 32, 90123, Palermo, Italy
6 shared publications- Delia Mandracchia
Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy
4 shared publications Fabio Salvatore Palumbo
Università degli Studi di Palermo
4 shared publications- Giuseppe Tripodo
Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy
4 shared publications F. S. Palumbo
Dipartimento di Chimica e Tecnologie Farmaceutiche, Università degli Studi di Palermo, via Archirafi 32, 90123 Palermo, Italy
3 shared publications
Latest Publications
- 3 November 2011
- Published by Springer Nature in Macromolecular Research
- Vol. 19 (12) , 1264-1271
Mechanical characterization of polysaccharide/polyaminoacid hydrogels as potential scaffolds for tissue regeneration
- 3 November 2011
- Published by Springer Nature in Macromolecular Research
- Vol. 19 (12) , 1264-1271
Mechanical characterization of polysaccharide/polyaminoacid hydrogels as potential scaffolds for tissue regeneration
- 1 December 2009
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 382 (1-2) , 7-14
Polysaccharide/polyaminoacid composite scaffolds for modified DNA release
- 1 December 2009
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 382 (1-2) , 7-14
Polysaccharide/polyaminoacid composite scaffolds for modified DNA release
- 2 November 2009
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 18 (4) , 264-276
Self-assembled amphiphilic hyaluronic acid graft copolymers for targeted release of antitumoral drug
Polymeric micelles obtained by self-assembling of amphiphilic hyaluronic acid (HA) graft copolymers have been prepared and characterized. In particular, hyaluronic acid (HA) has been grafted to polylactic acid (PLA) and polyethylenglycol chains (PEG), then the copolymers able to form micelles in aqueous medium have been chosen to entrap the antitumoral drug Doxorubicin. The critical aggregation concentration of HA-g-PLA or HA-g-PLA-g-PEG micelles has been determined by using pyrene as a fluorescent probe, whereas their shape and size have been evaluated by light scattering measurements, scanning and transmission electron microscopies. The selective cytotoxicity of drug loaded micelles toward the CD-44 over-expressing HCT-116 cells compared to receptor deficient human derm fibroblasts has been demonstrated. Pegylated micelles showed better stability and drug loading capacity and they were able to escape from macrophage phagocytosis.
- 2 November 2009
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 18 (4) , 264-276
Self-assembled amphiphilic hyaluronic acid graft copolymers for targeted release of antitumoral drug
Polymeric micelles obtained by self-assembling of amphiphilic hyaluronic acid (HA) graft copolymers have been prepared and characterized. In particular, hyaluronic acid (HA) has been grafted to polylactic acid (PLA) and polyethylenglycol chains (PEG), then the copolymers able to form micelles in aqueous medium have been chosen to entrap the antitumoral drug Doxorubicin. The critical aggregation concentration of HA-g-PLA or HA-g-PLA-g-PEG micelles has been determined by using pyrene as a fluorescent probe, whereas their shape and size have been evaluated by light scattering measurements, scanning and transmission electron microscopies. The selective cytotoxicity of drug loaded micelles toward the CD-44 over-expressing HCT-116 cells compared to receptor deficient human derm fibroblasts has been demonstrated. Pegylated micelles showed better stability and drug loading capacity and they were able to escape from macrophage phagocytosis.
- 1 April 2009
- Published by Wiley in Macromolecular Bioscience
- Vol. 9 (4) , 393-401
Controlled Release of IgG by Novel UV Induced Polysaccharide/Poly(amino acid) Hydrogels
The development of new protein and peptide drugs needs new delivery systems able to entrap such drugs in safe conditions without affecting their structure and biological activity. In this context, the present work reports a new approach to load IgG, used as a model of therapeutic proteins such as anti‐TNF‐α monoclonal antibodies, into a polymeric system able to release the entrapped IgG in a controlled manner. In particular, new polysaccharide/poly(amino acid) UV induced hydrogels are proposed as colon delivery systems for human IgG. The poly(amino acid), α,β‐poly[N‐(2‐hydroxyethyl)‐D,L‐aspartamide], has been functionalized with methacrylic anhydride, while the polysaccharide, inulin, has been functionalized with methacrylic anhydride and succinic anhydride. The hydrogels were obtained by a short‐time UV irradiation, in physiological‐like conditions, without the use of radical initiators, at low temperature and in the presence or in the absence of PEGDM550 used as a co‐crosslinker in order to evaluate potential differences in terms of physicochemical properties and release profile. The obtained hydrogels were degradable by inulinase, showed a high cell compatibility and the released antibodies, analyzed by SEC and ELISA, retained their biological activity. magnified image
- 1 April 2009
- Published by Wiley in Macromolecular Bioscience
- Vol. 9 (4) , 393-401
Controlled Release of IgG by Novel UV Induced Polysaccharide/Poly(amino acid) Hydrogels
The development of new protein and peptide drugs needs new delivery systems able to entrap such drugs in safe conditions without affecting their structure and biological activity. In this context, the present work reports a new approach to load IgG, used as a model of therapeutic proteins such as anti‐TNF‐α monoclonal antibodies, into a polymeric system able to release the entrapped IgG in a controlled manner. In particular, new polysaccharide/poly(amino acid) UV induced hydrogels are proposed as colon delivery systems for human IgG. The poly(amino acid), α,β‐poly[N‐(2‐hydroxyethyl)‐D,L‐aspartamide], has been functionalized with methacrylic anhydride, while the polysaccharide, inulin, has been functionalized with methacrylic anhydride and succinic anhydride. The hydrogels were obtained by a short‐time UV irradiation, in physiological‐like conditions, without the use of radical initiators, at low temperature and in the presence or in the absence of PEGDM550 used as a co‐crosslinker in order to evaluate potential differences in terms of physicochemical properties and release profile. The obtained hydrogels were degradable by inulinase, showed a high cell compatibility and the released antibodies, analyzed by SEC and ELISA, retained their biological activity. magnified image
- 30 November 2008
- Published by Elsevier in Journal of Fluorine Chemistry
- Vol. 129 (11) , 1096-1103
Fluorinated derivatives of a polyaspartamide bearing polyethylene glycol chains as oxygen carriers
- 30 November 2008
- Published by Elsevier in Journal of Fluorine Chemistry
- Vol. 129 (11) , 1096-1103
Fluorinated derivatives of a polyaspartamide bearing polyethylene glycol chains as oxygen carriers
- 29 September 2008
- Published by Wiley in Macromolecular Bioscience
- Vol. 8 (10) , 891-902
Hydrogels for Potential Colon Drug Release by Thiol‐ene Conjugate Addition of a New Inulin Derivative
Inulin was chosen as a starting polymer for biocompatible, pH‐sensitive and biodegradable hydrogels. Three INUDVSA‐TT hydrogels were obtained by crosslinking inulin derivatives with trimethylolpropane tris(3‐mercaptopropionate) under varying conditions. The resulting hydrogels were cell compatible, as demonstrated by MTS and trypan blue exclusion assays acting on Caco‐2 cells, and were biodegraded by inulinase and esterase, thus suggesting their use as colonic drug delivery systems. 2‐Methoxyestradiol, an anti‐cancer drug, was soaked in INUDVSA‐TT hydrogels and its in vitro release and apoptotic effect on Caco‐2 cells were evaluated. magnified image
- 29 September 2008
- Published by Wiley in Macromolecular Bioscience
- Vol. 8 (10) , 891-902
Hydrogels for Potential Colon Drug Release by Thiol‐ene Conjugate Addition of a New Inulin Derivative
Inulin was chosen as a starting polymer for biocompatible, pH‐sensitive and biodegradable hydrogels. Three INUDVSA‐TT hydrogels were obtained by crosslinking inulin derivatives with trimethylolpropane tris(3‐mercaptopropionate) under varying conditions. The resulting hydrogels were cell compatible, as demonstrated by MTS and trypan blue exclusion assays acting on Caco‐2 cells, and were biodegraded by inulinase and esterase, thus suggesting their use as colonic drug delivery systems. 2‐Methoxyestradiol, an anti‐cancer drug, was soaked in INUDVSA‐TT hydrogels and its in vitro release and apoptotic effect on Caco‐2 cells were evaluated. magnified image
- 15 January 2008
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 87A (3) , 770-779
Scaffolds based on hyaluronan crosslinked with a polyaminoacid: Novel candidates for tissue engineering application
New porous scaffolds, with a suitable hydrolytic and enzymatic degradation, useful for tissue engineering applications have been obtained by a carbodiimide mediated reaction between hyaluronan (HA) and a synthetic polymer with a polyaminoacid structure such as α,β‐polyaspartylhydrazide (PAHy). Scaffolds with a different molar ratio between PAHy repeating units and HA repeating units have been prepared and characterized from a chemical and physicochemical point of view. Tests of indirect and direct cytotoxicity, cell adhesion, and spreading on these biomaterials have been performed by using murine L929 fibroblasts. The new biomaterials showed a good cell compatibility and ability to allow cell migration into the scaffolds as well as spreading on their surface. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2008
- 15 January 2008
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 87A (3) , 770-779
Scaffolds based on hyaluronan crosslinked with a polyaminoacid: Novel candidates for tissue engineering application
New porous scaffolds, with a suitable hydrolytic and enzymatic degradation, useful for tissue engineering applications have been obtained by a carbodiimide mediated reaction between hyaluronan (HA) and a synthetic polymer with a polyaminoacid structure such as α,β‐polyaspartylhydrazide (PAHy). Scaffolds with a different molar ratio between PAHy repeating units and HA repeating units have been prepared and characterized from a chemical and physicochemical point of view. Tests of indirect and direct cytotoxicity, cell adhesion, and spreading on these biomaterials have been performed by using murine L929 fibroblasts. The new biomaterials showed a good cell compatibility and ability to allow cell migration into the scaffolds as well as spreading on their surface. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2008
- 6 July 2007
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 84A (2) , 413-424
Crosslinked hyaluronan with a protein‐like polymer: Novel bioresorbable films for biomedical applications
In this work, novel hydrogel films based on hyaluronan (HA) chemically crosslinked with the α,β‐poly(N‐2‐hydroxyethyl) (2‐aminoethylcarbamate)‐D,L‐aspartamide (PHEA–EDA) were produced by solution casting method. The goal was to exploit both the biological key role of HA in tissue repair and regeneration, and the versatility of a synthetic protein‐like polymer as the PHEA–EDA, in order to obtain biomaterials with physicochemical and biological properties suitable for a clinical use. By varying the molar ratio between the PHEA–EDA amino groups and HA carboxyl groups, three different films were obtained and characterized. Particularly FTIR, swelling, hydrolysis, and enzymatic degradation studies were performed. In addition, the cytocompatibility of HA/PHEA–EDA hydrogel films was evaluated using human derm fibroblasts, by means of MTT and trypan blue exclusion assays. The high swelling capability, the long‐term hydrolysis resistance, and the resistance to hyaluronidase greater than that of only HA, together with the cell compatibility, have suggested the potential application of these novel HA‐based hydrogel films in the biomedical field of tissue engineering. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2008
- 6 July 2007
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 84A (2) , 413-424
Crosslinked hyaluronan with a protein‐like polymer: Novel bioresorbable films for biomedical applications
In this work, novel hydrogel films based on hyaluronan (HA) chemically crosslinked with the α,β‐poly(N‐2‐hydroxyethyl) (2‐aminoethylcarbamate)‐D,L‐aspartamide (PHEA–EDA) were produced by solution casting method. The goal was to exploit both the biological key role of HA in tissue repair and regeneration, and the versatility of a synthetic protein‐like polymer as the PHEA–EDA, in order to obtain biomaterials with physicochemical and biological properties suitable for a clinical use. By varying the molar ratio between the PHEA–EDA amino groups and HA carboxyl groups, three different films were obtained and characterized. Particularly FTIR, swelling, hydrolysis, and enzymatic degradation studies were performed. In addition, the cytocompatibility of HA/PHEA–EDA hydrogel films was evaluated using human derm fibroblasts, by means of MTT and trypan blue exclusion assays. The high swelling capability, the long‐term hydrolysis resistance, and the resistance to hyaluronidase greater than that of only HA, together with the cell compatibility, have suggested the potential application of these novel HA‐based hydrogel films in the biomedical field of tissue engineering. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2008
- 4 June 2007
- Published by Wiley in Macromolecular Bioscience
- Vol. 7 (6) , 836-845
Fluoropolymer Based on a Polyaspartamide containing 1,2,4‐Oxadiazole Units: A Potential Artificial Oxygen (O2) Carrier
In this preliminary work we have prepared a fluorinated polymer capable of solubilizing an appreciable amount of O2 and, at the same time, maintaining a higher water solubility than perfluoroalkanes investigated as injectable O2 carriers. In particular, we describe the synthesis and characterization of a new macromolecular conjugate obtained by derivatization of α,β‐poly(N‐2‐hydroxyethyl)‐DL‐aspartamide (PHEA) with 5‐pentafluorophenyl‐3‐perfluoroheptyl‐1,2,4‐oxadiazole, called PHEA‐F. This new water soluble fluoropolymer was prepared in high yield using a simple procedure. It was characterized by FT‐IR and UV‐vis spectrophotometry, 19F‐NMR and SEC measurements. O2 solubility studies on PHEA‐F aqueous solutions were carried out at 25 °C and 37 °C at atmospheric pressure and showed that PHEA‐F conjugate, despite its low degree of derivatization in fluorine containing groups (2.60 mol‐%), is capable of dissolving 13–15% more O2 than non‐fluorinated PHEA. Moreover, O2 release in simulated physiological conditions is faster for PHEA‐F than for PHEA. The biocompatibility of this conjugate has been evaluated by performing an in vitro viability assay on human chronic myelogenous leukaemia cells (K‐562) chosen as a model cell line and in vitro haemolysis experiments on human RBCs. All these properties suggest the potential use of PHEA‐F as an artificial O2 carrier. magnified image
- 4 June 2007
- Published by Wiley in Macromolecular Bioscience
- Vol. 7 (6) , 836-845
Fluoropolymer Based on a Polyaspartamide containing 1,2,4‐Oxadiazole Units: A Potential Artificial Oxygen (O2) Carrier
In this preliminary work we have prepared a fluorinated polymer capable of solubilizing an appreciable amount of O2 and, at the same time, maintaining a higher water solubility than perfluoroalkanes investigated as injectable O2 carriers. In particular, we describe the synthesis and characterization of a new macromolecular conjugate obtained by derivatization of α,β‐poly(N‐2‐hydroxyethyl)‐DL‐aspartamide (PHEA) with 5‐pentafluorophenyl‐3‐perfluoroheptyl‐1,2,4‐oxadiazole, called PHEA‐F. This new water soluble fluoropolymer was prepared in high yield using a simple procedure. It was characterized by FT‐IR and UV‐vis spectrophotometry, 19F‐NMR and SEC measurements. O2 solubility studies on PHEA‐F aqueous solutions were carried out at 25 °C and 37 °C at atmospheric pressure and showed that PHEA‐F conjugate, despite its low degree of derivatization in fluorine containing groups (2.60 mol‐%), is capable of dissolving 13–15% more O2 than non‐fluorinated PHEA. Moreover, O2 release in simulated physiological conditions is faster for PHEA‐F than for PHEA. The biocompatibility of this conjugate has been evaluated by performing an in vitro viability assay on human chronic myelogenous leukaemia cells (K‐562) chosen as a model cell line and in vitro haemolysis experiments on human RBCs. All these properties suggest the potential use of PHEA‐F as an artificial O2 carrier. magnified image
- 1 June 2007
- Published by Elsevier in Journal of Controlled Release
- Vol. 119 (3) , 328-338
Photocrosslinking of dextran and polyaspartamide derivatives: A combination suitable for colon-specific drug delivery
- 1 June 2007
- Published by Elsevier in Journal of Controlled Release
- Vol. 119 (3) , 328-338
Photocrosslinking of dextran and polyaspartamide derivatives: A combination suitable for colon-specific drug delivery